A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
08/2006
08/30/2006	CN1272433C Nucleic acid sequence for potentiating the expression of useful gene and method therefor
08/30/2006	CN1271992C Cationic virosomes as transfer system for genetic material
08/29/2006	US7098375 Animal and cell models for type II diabetes and their use
08/29/2006	US7098323 Polynucleotide squences and amino acid sequences for diagnosis of diseases and growth factors
08/29/2006	US7098316 Isolated nucleic acid, coding regions of genes of proteins, vectors, host cells and genetic engineering for producing proteins and diagnosis of diseaes
08/29/2006	US7098192 Antisense oligonucleotide modulation of STAT3 expression
08/29/2006	US7098191 Hyperthermic inducible expression vectors for gene therapy and methods of use thereof
08/29/2006	US7098190 Formulations comprising antisense nucleotides to connexins
08/29/2006	US7098183 cell growth differentiation factors/polypeptides for immunization; animal models
08/29/2006	US7098032 Delivering a nucleic acid to a cell; condensing nucleic acid with polyampholyte to complex; crosslinking polyampholyte; contacting with cell; gene therapy
08/29/2006	US7098031 Random integration of a polynucleotide by in vivo linearization
08/29/2006	US7098025 Human peroxisome proliferator activated receptor gamma (pparγ) gene regulatory sequences and uses therefor
08/29/2006	US7098012 DNA demethylase, therapeutic and diagnostic uses thereof
08/29/2006	US7098004 Isolated polypeptide of the stratum corneum and its use
08/29/2006	US7097994 UDP-N-acetylglucosamine:galactose-β1,3-N-acetylgalactosamine-α-R/ (GlcNAc to GaINAc) β1-6 N-acetylglucosaminyltransferase, C2GnT3
08/29/2006	US7097992 Uses of human UDP-glucuronosyltransferase 2B7 to detect and treat cancer
08/29/2006	US7097985 for the treatment of leukemia, tumors, chronic infections, autoimmune disease, fibrotic disorders, wound healing and psoriasis
08/29/2006	US7097972 invention provides non-naturally occurring and isolated naturally occurring nucleic acid molecules which code proteins designated Yama Pro-Yama and non-naturally occurring nucleic acid molecule coding mutant CrmA protein and dominant inhibitory Yama.Vectors and host cells containing these nucleic acids
08/29/2006	US7097854 Amino alcohol derivatives, process for their production and pharmaceutical preparations and reagents containing these compounds
08/29/2006	US7097842 Modified vaccinia virus ankara for the vaccination of neonates
08/29/2006	US7097838 Antagonists of HMG1 for treating inflammatory conditions
08/29/2006	US7097834 Osteoprotegerin binding proteins
08/29/2006	US7097829 Transgenic cells transfected with pituitary tumor transforming gene (PTTG)) expression vectors and uses therefor
08/29/2006	US7097823 Administering a RADIONUCLIDE COMPLEXED WITH A CHELATING AGENT SUCH AS MACROCYCLIC AMINOPHOSPHONIC ACID, or tetraazacyclododecanetetramethylenephosphonic acid (DOTMP); osteomyelitis treatment
08/24/2006	WO2006089270A2 Methods of modifying insulin signaling using biliverdin reductase
08/24/2006	WO2006089087A2 Compositions, kits and methods for identification, assessment, prevention and therapy of cancer
08/24/2006	WO2006089001A2 Lentiviral vectors and their use
08/24/2006	WO2006088888A2 Aptamer therapeutics useful in the treatment of complement-related disorders
08/24/2006	WO2006088229A1 Modified virus capsid protein and the use thereof
08/24/2006	WO2006088219A1 Il-13 production inhibitor
08/24/2006	WO2006088010A1 Antimicrobial peptide and use thereof
08/24/2006	WO2006087637A2 Anti her2/neu antibody
08/24/2006	WO2006086838A1 Flavivirus replicon constructs for tumour therapy
08/24/2006	WO2006040330A3 Improved adenoviral vectors and uses thereof
08/24/2006	WO2006031213A8 Single -pass image warping system and mehtod with anisotropic filtering
08/24/2006	WO2005120581A3 Gene therapy for neurometabolic disorders
08/24/2006	US20060189785 Using biocompatible, low molecular weighty, water solubler polymer; injectable
08/24/2006	US20060189564 Direct delivery of inhibitory nucleic acid molecules to perispinal region or intrathecal space of spinal cord utilizing catheter and drug pump
08/24/2006	US20060189563 Detection and modulation of IAPS and NAIP for the diagnosis and treatment of proliferative disease
08/24/2006	US20060189562 In vitro-differentiated retinal ganglion cells and method for producing same
08/24/2006	US20060189561 RNAi expression constructs with liver-specific enhancer/promoter
08/24/2006	US20060189560 Molecular method to augment RNA mediated gene silencing
08/24/2006	US20060189559 Method and system for treating hepatitis C
08/24/2006	US20060189558 Delivery of substances to cells
08/24/2006	US20060189557 increasing the sensitivity of a cell or tissues to cytotoxic cancer therapy with a naturally occurring nucleic acids
08/24/2006	US20060189556 Genes encoding Mycobacterium bovis bacillus Calmette-Guerin (M. bovis BCG) recombinant antigens and those for interleukin-12 heterodimer were respectively cloned into eukaryotic expression vectors; attenuating or suppressing the growth of bladder cancer cells
08/24/2006	US20060189555 Pyrroles substituted by oligonucleotides
08/24/2006	US20060189554 Nanoparticle-Based vaccine delivery system containing adjuvant
08/24/2006	US20060189553 Drug delivery of polynucleotide to primate hepatocyte; high level of gene expression with transient increases in liver enzymes
08/24/2006	US20060189550 Immunostimulatory, Covalently lipidated oligonucleotides
08/24/2006	US20060189530 Neuropeptide Y receptor Y5 and nucleic acid sequences
08/24/2006	US20060189521 Human Liver Regeneration Associated Protein and the Use Thereof
08/24/2006	US20060189518 Preventing/remedies for cancer
08/24/2006	US20060188991 Flexible vaccine assembly and vaccine delivery platform
08/24/2006	US20060188990 Novel prostate tumor-specific promoter
08/24/2006	US20060188989 Inhibition of E3-ubiquitin ligase HAKAI for treatment of proliferative disorders
08/24/2006	US20060188975 Genetically modified somatic cells for sustained secretion of lysosomal proenzymes deficient in lysosomal storage disorders
08/24/2006	US20060188957 Novel TNF receptor death domain ligand proteins and inhibitors of ligand binding
08/24/2006	US20060188913 Methods and products for enhancing immune responses using imidazoquinoline compounds
08/24/2006	US20060188577 Element having bioactive substance fixed thereto
08/24/2006	US20060188560 Delivery system for nucleic acids
08/24/2006	US20060188527 Methods for vaccinating against malaria
08/24/2006	US20060188522 Viral agents
08/24/2006	US20060188521 Disrupting sex steroid signal to thymus: bone marrow or hematopoietic cells
08/24/2006	US20060188516 Chlamydia trachomatis antigens
08/24/2006	US20060188507 Methods for identifying chemotherapeutic resistance in non-hematopoietic tumors
08/24/2006	US20060188506 Therapy-enhancing glucan
08/24/2006	US20060188501 Diagnostic and therapeutic agents for rheumatoid arthritis
08/24/2006	US20060188491 Use of nuclear material to therapeutically reprogram differentiated cells
08/24/2006	US20060188490 Transfection of blood cells with mRNA for immune stimulation and gene therapy
08/24/2006	US20060188489 Methods and materials for increasing potency of cells
08/24/2006	US20060188488 Prevascularized constructs for implantation to provide blood perfusion
08/24/2006	US20060188484 Virus vectors and methods of making and administering the same
08/24/2006	US20060188483 Virus vectors and methods of making and administering the same
08/24/2006	US20060188482 Methods for delivering recombinant adeno-associated virus virions to the liver of a mammal
08/24/2006	US20060188481 Methods for prophylactically or therapeutically treating an animal for an ocular-related disorder
08/24/2006	US20060188480 Viral vectors
08/24/2006	US20060188479 Plasmid for tissue targeted treatment of tumors; antitumor agents
08/24/2006	US20060188477 Use of interferon alpha 5 in the treatment of viral liver diseases
08/24/2006	US20060188472 HAS-active ingredient conjugates
08/24/2006	US20060188442 X-ray guided drug delivery
08/24/2006	DE60115613T2 Herstellung von rekombinanten muteine des blutgerinnungsfaktors viii in humanen zellinien Production of recombinant muteins of the blood coagulation factor viii in human cell lines
08/24/2006	CA2598535A1 Anti her2/neu antibody
08/24/2006	CA2598269A1 Methods of modifying insulin signaling using biliverdin reductase
08/24/2006	CA2597928A1 Lentiviral vectors and their use
08/24/2006	CA2597889A1 Aptamer therapeutics useful in the treatment of complement-related disorders
08/24/2006	CA2597708A1 Metabolic-based methods for modulating gene expression
08/24/2006	CA2597655A1 Flavivirus replicon constructs for tumour therapy
08/24/2006	CA2596509A1 Interleukin-17f antibodies and other il-17f signaling antagonists and uses therefor
08/24/2006	CA2595699A1 Compositions, kits and methods for identification, assessment, prevention and therapy of cancer
08/24/2006	CA2572151A1 Oligonucleotides comprising a non-phosphate backbone linkage
08/23/2006	EP1693460A1 Method of regulating heterologous protein expression controlled by salicylic derivatives in micro-organisms associated with higher organisms
08/23/2006	EP1693459A1 Chimeric type 5/type 11 or type 35 adenovirus vector for preventing infection with antihuman immunodeficiency virus
08/23/2006	EP1693451A1 Method of growing myocardial cells
08/23/2006	EP1693384A2 Functional immunoglobulins against human serum albumin, fragments thereof, library thereof and methods of production thereof
08/23/2006	EP1693379A1 Protein nmb0928 and use thereof in pharmaceutical formulations
08/23/2006	EP1693378A2 Protein nmb1125 and use thereof in pharmaceutical formulations
08/23/2006	EP1693068A1 Use of M. tuberculosis chaperonin 60.1 for the treatment of arthritis
08/23/2006	EP1693062A2 Androgen receptor-dependent gene expression control
08/23/2006	EP1692521A1 Rbp4 in insulin sensitivity/resistance, diabetes, and obesity

1 ... 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 ... 870